fig3
Figure 3. Progression-Free Survival probability to VEGFR-TKI monotherapy in first-line according to time after therapy initiation in the study population, divided by presence/absence of sarcomatoid features.
Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)
Navigation
Follow Us
Navigation
Portico
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/
